These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 25079908)

  • 1. Toxicity of protein oligomers is rationalized by a function combining size and surface hydrophobicity.
    Mannini B; Mulvihill E; Sgromo C; Cascella R; Khodarahmi R; Ramazzotti M; Dobson CM; Cecchi C; Chiti F
    ACS Chem Biol; 2014 Oct; 9(10):2309-17. PubMed ID: 25079908
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glycosaminoglycans (GAGs) suppress the toxicity of HypF-N prefibrillar aggregates.
    Saridaki T; Zampagni M; Mannini B; Evangelisti E; Taddei N; Cecchi C; Chiti F
    J Mol Biol; 2012 Aug; 421(4-5):616-30. PubMed ID: 22326346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Salt anions promote the conversion of HypF-N into amyloid-like oligomers and modulate the structure of the oligomers and the monomeric precursor state.
    Campioni S; Mannini B; López-Alonso JP; Shalova IN; Penco A; Mulvihill E; Laurents DV; Relini A; Chiti F
    J Mol Biol; 2012 Dec; 424(3-4):132-49. PubMed ID: 23041425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A causative link between the structure of aberrant protein oligomers and their toxicity.
    Campioni S; Mannini B; Zampagni M; Pensalfini A; Parrini C; Evangelisti E; Relini A; Stefani M; Dobson CM; Cecchi C; Chiti F
    Nat Chem Biol; 2010 Feb; 6(2):140-7. PubMed ID: 20081829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transthyretin suppresses the toxicity of oligomers formed by misfolded proteins in vitro.
    Cascella R; Conti S; Mannini B; Li X; Buxbaum JN; Tiribilli B; Chiti F; Cecchi C
    Biochim Biophys Acta; 2013 Dec; 1832(12):2302-14. PubMed ID: 24075940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of molecular chaperones on aberrant protein oligomers in vitro: super-versus sub-stoichiometric chaperone concentrations.
    Cappelli S; Penco A; Mannini B; Cascella R; Wilson MR; Ecroyd H; Li X; Buxbaum JN; Dobson CM; Cecchi C; Relini A; Chiti F
    Biol Chem; 2016 May; 397(5):401-15. PubMed ID: 26812789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural differences between toxic and nontoxic HypF-N oligomers.
    Capitini C; Patel JR; Natalello A; D'Andrea C; Relini A; Jarvis JA; Birolo L; Peduzzo A; Vendruscolo M; Matteini P; Dobson CM; De Simone A; Chiti F
    Chem Commun (Camb); 2018 Aug; 54(62):8637-8640. PubMed ID: 30020284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conformational properties of the aggregation precursor state of HypF-N.
    Campioni S; Mossuto MF; Torrassa S; Calloni G; de Laureto PP; Relini A; Fontana A; Chiti F
    J Mol Biol; 2008 Jun; 379(3):554-67. PubMed ID: 18466920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amyloid-β oligomer synaptotoxicity is mimicked by oligomers of the model protein HypF-N.
    Tatini F; Pugliese AM; Traini C; Niccoli S; Maraula G; Ed Dami T; Mannini B; Scartabelli T; Pedata F; Casamenti F; Chiti F
    Neurobiol Aging; 2013 Sep; 34(9):2100-9. PubMed ID: 23601807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toxic oligomers of the amyloidogenic HypF-N protein form pores in mitochondrial membranes.
    Farrugia MY; Caruana M; Ghio S; Camilleri A; Farrugia C; Cauchi RJ; Cappelli S; Chiti F; Vassallo N
    Sci Rep; 2020 Oct; 10(1):17733. PubMed ID: 33082392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Searching for conditions to form stable protein oligomers with amyloid-like characteristics: The unexplored basic pH.
    Ahmad B; Winkelmann J; Tiribilli B; Chiti F
    Biochim Biophys Acta; 2010 Jan; 1804(1):223-34. PubMed ID: 19836473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-level expression of a folding-incompetent protein in Escherichia coli: search for the molecular determinants of protein aggregation in vivo.
    Winkelmann J; Calloni G; Campioni S; Mannini B; Taddei N; Chiti F
    J Mol Biol; 2010 May; 398(4):600-13. PubMed ID: 20346957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure and dynamics of a partially folded protein are decoupled from its mechanism of aggregation.
    Calloni G; Lendel C; Campioni S; Giannini S; Gliozzi A; Relini A; Vendruscolo M; Dobson CM; Salvatella X; Chiti F
    J Am Chem Soc; 2008 Oct; 130(39):13040-50. PubMed ID: 18767849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The induction of α-helical structure in partially unfolded HypF-N does not affect its aggregation propensity.
    Ahmad B; Vigliotta I; Tatini F; Campioni S; Mannini B; Winkelmann J; Tiribilli B; Chiti F
    Protein Eng Des Sel; 2011 Jul; 24(7):553-63. PubMed ID: 21518735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trodusquemine displaces protein misfolded oligomers from cell membranes and abrogates their cytotoxicity through a generic mechanism.
    Limbocker R; Mannini B; Ruggeri FS; Cascella R; Xu CK; Perni M; Chia S; Chen SW; Habchi J; Bigi A; Kreiser RP; Wright AK; Albright JA; Kartanas T; Kumita JR; Cremades N; Zasloff M; Cecchi C; Knowles TPJ; Chiti F; Vendruscolo M; Dobson CM
    Commun Biol; 2020 Aug; 3(1):435. PubMed ID: 32792544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of the biochemical modifications caused by toxic and non-toxic protein oligomers in cells.
    Zampagni M; Cascella R; Casamenti F; Grossi C; Evangelisti E; Wright D; Becatti M; Liguri G; Mannini B; Campioni S; Chiti F; Cecchi C
    J Cell Mol Med; 2011 Oct; 15(10):2106-16. PubMed ID: 21155974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure of [NiFe] hydrogenase maturation protein HypE from Escherichia coli and its interaction with HypF.
    Rangarajan ES; Asinas A; Proteau A; Munger C; Baardsnes J; Iannuzzi P; Matte A; Cygler M
    J Bacteriol; 2008 Feb; 190(4):1447-58. PubMed ID: 18065529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Binding affinity of amyloid oligomers to cellular membranes is a generic indicator of cellular dysfunction in protein misfolding diseases.
    Evangelisti E; Cascella R; Becatti M; Marrazza G; Dobson CM; Chiti F; Stefani M; Cecchi C
    Sci Rep; 2016 Sep; 6():32721. PubMed ID: 27619987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure of hydrogenase maturation protein HypF with reaction intermediates shows two active sites.
    Petkun S; Shi R; Li Y; Asinas A; Munger C; Zhang L; Waclawek M; Soboh B; Sawers RG; Cygler M
    Structure; 2011 Dec; 19(12):1773-83. PubMed ID: 22153500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of toxic and non-toxic HypF-N oligomers with lipid bilayers investigated at high resolution with atomic force microscopy.
    Oropesa-Nuñez R; Seghezza S; Dante S; Diaspro A; Cascella R; Cecchi C; Stefani M; Chiti F; Canale C
    Oncotarget; 2016 Jul; 7(29):44991-45004. PubMed ID: 27391440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.